COMPANY

NERx Biosciences

HQ: Indianapolis, IN source · nerxbiosciences.com ↗ · Midwest

Also known as NERX BIOSCIENCES, INC. · 9 sources

Keywords: oncology cancer

Location: Indianapolis, IN · source · Oct 15, 2026

Profile checked Oct 10, 2026

8NIH grants

Timeline

Aug 21, 2025 Grant Government grant — SBIR: $921,320 (annual award, as published), announced Aug 21, 2025. Agency: NIH/NCI. Source: government award database. source ↗

Funding

Last 2 years.

Aug 21, 2025 Government grant — SBIR: $921,320 (annual award, as published), announced Aug 21, 2025. Agency: NIH/NCI. Source: government award database. source ↗

NIH awards 8

Annual award amounts. Total $2.6M.

Aug 1, 2024 NIH award 1R44CA287693-01A1 FY2024: $1,078,680 awarded for that fiscal year; activity R44 (SBIR); PI PAWELCZAK, KATHERINE; recipient as written: NERX BIOSCIENCES, INC., INDIANAPOLIS, IN. Targeting the DNA Damage Resp source ↗
Aug 24, 2017 NIH award 1R43CA221562-01 FY2017: $300,000 awarded for that fiscal year; activity R43 (SBIR); PI PAWELCZAK, KATHERINE; recipient as written: NERX BIOSCIENCES, INC., INDIANAPOLIS, IN. Development of novel Ku targeted source ↗
Jan 13, 2017 NIH award 3R41CA195926-01S1 FY2017: $49,844 awarded for that fiscal year; activity R41 (STTR); PI PAWELCZAK, KATHERINE; recipient as written: NERX BIOSCIENCES, INC., INDIANAPOLIS, IN. A new generation of targeted the source ↗
May 26, 2016 NIH award 1R43GM119880-01 FY2016: $293,005 awarded for that fiscal year; activity R43 (SBIR); PI PAWELCZAK, KATHERINE; recipient as written: NERX BIOSCIENCES, INC., INDIANAPOLIS, IN. Chemical enhancement of CRISPR/Ca source ↗
May 15, 2015 NIH award 1R41CA195926-01 FY2015: $249,431 awarded for that fiscal year; activity R41 (STTR); PI PAWELCZAK, KATHERINE; recipient as written: NERX BIOSCIENCES, INC., INDIANAPOLIS, IN. Development of novel lung cancer source ↗
Jul 25, 2013 NIH award 3R41CA162648-01S1 FY2013: $131,247 awarded for that fiscal year; activity R41 (STTR); PI TURCHI, JOHN J.; recipient as written: NERX BIOSCIENCES, INC., INDIANAPOLIS, IN. Development of Novel Agents Targetin source ↗
Sep 26, 2012 NIH award 1R43CA165848-01A1 FY2012: $299,922 awarded for that fiscal year; activity R43 (SBIR); PI FELTGEN, ROBERT; recipient as written: NERX BIOSCIENCES, INC., INDIANAPOLIS, IN. Targeting the ERCC1/XPF nuclease for source ↗
Sep 21, 2012 NIH award 1R41CA162648-01 FY2012: $229,680 awarded for that fiscal year; activity R41 (STTR); PI TURCHI, JOHN J.; recipient as written: NERX BIOSCIENCES, INC., INDIANAPOLIS, IN. Development of Novel Agents Targeting source ↗